Patrick O’Brien | SVP of Investor Relations |
John Higgins | CEO |
Matt Foehr | COO |
Matt Korenberg | CFO |
Lucas Baranowski | Craig-Hallum |
Emanuela Branchetti | H.C. Wainwright |
Scott Henry | Roth Capital Partners |
Peter Lukas | CJS Securities |
Hello, and welcome to this webcast, Ligand Pharmaceuticals' Third Quarter 2019 Earnings Call. My name is Lira and I will be your event specialist today. Please note that all lines have been placed on mute to prevent any background noise and that today's webcast is being recorded. [Operator Instructions]
It is now my pleasure to turn today's program over to SVP of Investor Relations, Patrick O’Brien.